Member Info for JRDC

Surprised they haven't scrapped the ISA tax benefits, or reduced them to a lifetime allowance. Can't see them going after the corporation's, and EU won't allow a deal where we can undercut on corp tax, so it's the middle earners who will pay it back. Employer allowance will be next, then increase from 7.5% dividend band just to make running a company even more pointless.

I just hope that companies who have taken advantage of bounce back loans and furlough etc are responsible for paying more back in future years with higher corporation tax, esp if foreign owned. I don't want to be penalised for not taking up the option even though I would be entitled to it. IR35 can balls off this year.

Odx have one, but not the one they were hoping for

Interactive invester was buggered for me all day, forgot to check freetrade but given its not built on mid 90's infrastructure it probably ok

Twitter has people moaning about stop losses. Some bloke who was in Avacta had a sl at £1.60, but the time it was executed it was sold at £1.00. kicking off at Hargreaves.

Anyway, not worried about sp here, patients vacinnated or not will still be swab tested in hospitals, still selling machines well in to next year.

It's my Avacta holding I'm more twitchy about, next 3 weeks are critical, let's hope the govt is still keen on testing in the spring. Stanley has gone quiet, so not all bad.

It will bounce tomorrow, cancer trial news due next, still expecting clinical validation RNS by Dec, testing will still be needed, especially as vaccine take-up will not be anywhere near enough to grant herd immunity, and we still need details on the vaccine and how it will handle mutations, all comes in SP could easily head back towards£2.

I just hope captainStanley is ok and not done anything daft.

Why don't you come over to the ncyt board where the knowledgeable members can educate you accuracy, winterplex etc instead of clogging up this board, as all it will result in is make rampers on here look daft. I, and other investors, come to this board for accurate information, not have to sift through misleading claims in the hope of ramping the share price, that will put new investors right off having to filter lies from fact. And don't slate them too much, theyll have enough cash to buy avacta next year if they so wished.

Stanley, you've been laughed off the NCYT board for talking bolox. NCYT have just completed their care home testing trial and are currently in the results stage after a delay. Not sure why you're so obsessed about them, they're doing just fine. Avacta will have its time in the spring helping with home testing which will be a huge market, but gold standard PCR will always be needed in clinical settings where nothing less than 100% accuracy will do. Two completely different markets. Even this govt aren't going to spend hundreds of millions on nova machines and then scrap them after 6 months.

It's the guardian who are only 2nd to the BBC in being anti Tory.

If bojo were to claim that Avacta will bring life back to normal I can guarantee that the guardian will find a way to slate the govt and how the tests are a complete failure. I pay as much attention to the guardian as I do the daily Star.

Had an email just now that the surescreen diagnostics test is now available. Have emailed for more information. These didn't bother with condor as the govt has sat on their antibody tests since march and not progressed further, so these worked with a university to get approval, think it was brum. They offer 2 tests, one is visual, other uses some handheld device but is more accurate. Clinical use only not for sale to general public.

Will order a few to see what they're like

Don't get me wrong, I'd love to see it before then, I'm just mentally prepared if we don't hear anything about clinical use approval by end of November

I'm just going by the timelines given to us by Avacta interview (clinical approval q4, self test market 2021 their words), what I've read into the cytiva interview other day and what govt have announced before about the spring target. Given how slow condor has been Avacta could well be ready to go for home use in Jan, but not on 10m units a month. Either we're not being told the whole story yet, or Al is waiting till early next year to scale up production. Just imo, I'm happy to wait.

If by summer nova are running the clinical tests in all hospitals and Avacta have a huge hand in self testing for next 36 months, I'll be a marginally happier man.

Whatever the govt announce, it will be a stopgap until our test is available in the spring. Best estimates are that covid will be around for 18 months, worst estimate is decades. There is no one boat, Avacta may be one of the later ones to market, much like apple didn't make a phone until 2007 and brought in new tech like capacitive touch screens, they've not done too badly since. We're bringing in new tech - affimers - which from reading should be pretty easy to tailor to future strains, much like PCR just needs a minor software update, hence it being the gold standard for 40 years. Can other lateral flow tests be tweaked as easily without having to go through validation?

https://www.biopharma-reporter.com/Article/2020/10/29/COVID-19-testing-will-remain-key-even-as-vaccines-enter-into-the-fray-says-Cytiva-as-it-invests-in-diagnostic-inventory-and-service-labs

There was an article was last night with interview from someone from cytiva, didn't post it as not particularly informative above what everyone has posted already, who basically said they're working with a partner to determine if a saliva test is viable. So imo doesn't sound iminent but is inline with my q1/q2 expectation.

Bams test is already available for research use, and Avacta will be receiving some income from that.

Until the market knows how to value covid stocks (regardless what people say, for now, avacta is above 50p because of its covid test potential) its difficult to tell. Nova on course for £550m revenue this year alone based on current news, they're releasing an LFD as leaked other day, which may poach some of their own PCR sales but also open up new markets. Sales of antibody tests have not been released yet, will probably become useful when vaccines are made available. Even at a tenner, the current SP looks damn cheap.

Avacta has huge potential around the use of affimers, far beyond covid. A successful covid test, whether it becomes the sole Govt choice or not, will put avacta squarely on the map of the big pharmas over the next 12-18 months, and other drugs companies looking to licence, which is where the big money will be.

I originally got in to avacta from nova having thought I'd make a quick buck by april next year on the covid test, but researching the company you'll see this is just a sidenote, this is going to be a long term stock. Cash raised from a hopefully successul covid test will be reinvested back in to the company advancing their affimer tech over the next 2-3 years and the cancer trials. Whereas nova will be spending theirs on acquisition to expand (or possibly be bought out), avacta already have a potential multi billion pound tech they just need to promote and perfect.

I'm heavy in Avacta, far more so than here now, but home approval won't happen until spring. The SP is already high there based on potential, which is why between now and mid Nov you'll see lots of volatility between £1 70 and £2.00.

Shorting nova this year will bankrupt you.

New Avacta timeline:

1st November, Al pays £30k deposit for a £110k 2 bed semi in Wakefield
7th November the Big RNS - MOVING IN DAY
12th November, nip down to Allied Carpets for living room, existing carpet covered in dog hair
3rd December Al + wife off to DFS as old sofa doesnt match the new carpet

On a serious note, these are shares that were worth pennies less than 12 months ago, and a house move would have been on the cards months ago. You wouldn't sell if you were expecting them to be worth double in a few weeks, so that tells me it will be 6 months+ before any huge rise, which is in line with my expectations - I've said before I'm not expecting any thing explosive until the spring, anyone whos done their research knows the big news will be home approval, which from their timeline is Q1-Q2 next year. He still has a sizable holding and options.

Do shorts have a deadline when they need to close? I wonder if they're banking on covid being controlled or new tests replacing PCR in next 18-24 months.

Nova are due the care home trials results which look to have been successful from rumours, plus french news due. They're on course to double again over next few months and will probably have their contract extended. I don't think any company is capable of 'gunning' for them this year.

Also I don't think big moves here will happen until q1 2021 for home use approval according to the Al interview. Bams and professional use approval due this year could move SP up nicely though, but everyone knows its the self/home test market that's going to be the worldwide game changer. Patience and in 6 months Avacta will have nova sized gains at least.

I think others thought the same too when it shot up to £6.50+, not ashamed to admit I sold a bit at 6.55, doubled my money there, not getting greedy